Partner Dan Shores will present a webinar titled "The mRNA/Lipid Nanoparticle Competitive and Litigation Landscape" for Medmarc, the leading expert in the products liability risks facing medical technology and life sciences companies. The webinar will take place on September 27, 2023, at 2 pm ET. The event is free of charge and open to the public.
While the COVID-19 pandemic caused tragedy for millions of families worldwide, it has also spurred concomitant advancements in health care, not the least of which include the first-ever regulatory approvals of therapies based on messenger RNA (mRNA) technology granted to Moderna and BioNTech (in collaboration with Pfizer). At the dawn of this new era in therapeutics, companies operating in this space are eager to develop and commercialize new mRNA-based drugs, but are also faced with the significant challenge of navigating an exceedingly complex IP, competitive, and litigation landscape. This webinar will provide a detailed survey of the current patent and patent litigation landscape for mRNA and lipid nanoparticle delivery technologies, as well as provide analytical frameworks for companies that operate in this space to utilize when navigating these complicated issues.
To view the webinar recording, or to access the webinar slides, please visit the event page on the Medmarc website.